EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 11 listopada 2024. Database contains 4821 unique substances/entries.
Filter the list
|
-
|
95342-41-9
|
yes |
|||
|
440-620-2
|
920-36-5
|
Water-react. 1; Pyr. Liq. 1; Skin Corr. 1A; STOT SE 3 |
|||
|
(2-BENZOTHIAZOLYLTHIO)BERNSTEINSÄURE; BTTBS; HALOX 650; IRGACOR 252
|
401-450-4
|
95154-01-1
|
Skin Sens. 1 |
||
|
NCC ETHER
|
406-100-4
|
94097-88-8
|
Skin Sens. 1 |
||
|
MEXORYL SX; SX 32
|
410-960-6
|
92761-26-7
|
Eye Dam. 1 |
||
|
D-HPPA; HPOPS
|
407-960-3
|
94050-90-5
|
Eye Dam. 1 |
||
|
PAYLEAN; RACTOPAMINE HYDROCHLORIDE
|
415-170-5
|
90274-24-1;99095-19-9
|
Acute Tox. 4; Skin Sens. 1 |
||
|
PAYLEAN; RACTOPAMINE HYDROCHLORIDE
|
415-170-5
|
90274-24-1;99095-19-9
|
Acute Tox. 4; Skin Sens. 1 |
||
|
T001446
|
419-600-2
|
99199-90-3
|
Skin Sens. 1 |
||
|
202-486-1
|
96-18-4
|
Carc. 1B; Repr. 1B; Acute Tox. 4 |
yes |
||